Skip to main content

About

Aims and scope

Inflammation and Regeneration is the official journal of the Japanese Society of Inflammation and Regeneration (JSIR). This journal provides an open access forum which covers a wide range of scientific topics in the basic and clinical researches on inflammation and regenerative medicine. It also covers investigations of infectious diseases, including COVID-19 and other emerging infectious diseases, which involve the inflammatory responses. Inflammation research and regenerative medicine are tightly linked research areas in life sciences and their significance in translational research is rapidly increasing. From this aspect, this journal encourages the submission of manuscripts whose scope bridges these fields of research.

The journal publishes papers in the following categories: research article, note, rapid communication, case report, review and clinical drug evaluation.

Open access

All articles published by Inflammation and Regeneration are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

As authors of articles published in Inflammation and Regeneration you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.

For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article processing charges (APC)

Authors who publish open access in Inflammation and Regeneration are required to pay an article processing charge (APC). The APC price will be determined from the date on which the article is accepted for publication.

The current APC, subject to VAT or local taxes where applicable, is: £1790.00/$2490.00/€2190.00

Visit our open access support portal and our Journal Pricing FAQs for further information.

Open access funding

Visit Springer Nature’s open access funding & support services for information about research funders and institutions that provide funding for APCs.

Springer Nature offers agreements that enable institutions to cover open access publishing costs. Learn more about our open access agreements to check your eligibility and discover whether this journal is included.

Springer Nature offers APC waivers and discounts for articles published in our fully open access journals whose corresponding authors are based in the world’s lowest income countries (see our APC waivers and discounts policy for further information). Requests for APC waivers and discounts from other authors will be considered on a case-by-case basis, and may be granted in cases of financial need (see our open access policies for journals for more information). All applications for discretionary APC waivers and discounts should be made at the point of manuscript submission; requests made during the review process or after acceptance are unable to be considered.

Information for JSIR members

(Information updated on 22 March 2023)

The Japanese Society of Inflammation and Regeneration covers the article-processing charge (APC) for the papers submitted by the member of the society and for the papers invited by the journal. To receive this benefit, the JSIR members and invited authors must claim the APC coverage at the time of editorial acceptance of their manuscript.

As from 22 March 2023, due to system change, authors are no longer requested to submit Membership Account Code to claim coverage of APC for society members/invited authors during the process of making new manuscript submission. Instead, members/invited authors are able to request APC coverage at editorial acceptance. 

See below for further information:

- Changes in manuscript submission *(in Japanese)
- To request APC coverage for JSIR members 

For questions, please contact the Society office.

Indexing services

All articles published in Inflammation and Regeneration are included in:

  • DOAJ
  • PubMed
  • PubMed Central
  • Emerging Sources Citation Index (ESCI)
  • Scopus
  • Google Scholar
  • EBSCO Discovery Service
  • OCLC WorldCat Discovery Service
  • ProQuest-ExLibris Summon
  • ProQuest-ExLibris Primo
  • Meta
  • Institute of Scientific and Technical Information of China
  • Naver
  • Chinese Academy of Sciences (CAS) - GoOA
  • EMBASE
  • Chemical Abstracts Services (CAS)

The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.

We are working closely with relevant indexing services including Web of Science (Clarivate Analytics) to ensure that articles published in Inflammation and Regeneration will be available in their databases when appropriate.

Peer-review policy

Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.

Inflammation and Regeneration operates using a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.

The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.

All submitted manuscripts are evaluated by the Editor-in-Chief and suitable manuscripts proceed to peer review, being assigned to a handling editor where appropriate. Comments are sought from at least two reviewers. Based on the reviews, the Editor-in-Chief or handling editor rejects, accepts or requests revisions of the manuscript.

Editorial policies

All manuscripts submitted to Inflammation and Regeneration should adhere to BioMed Central's editorial policies.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Citing articles in Inflammation and Regeneration

Articles in Inflammation and Regeneration should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Inflamm Regen [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Inflamm Regen 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Appeals and complaints

Authors who wish to appeal a rejection or make a complaint should follow the procedure outlined in the BMC Editorial Policies.

Benefits of publishing with BMC

High visibility

Inflammation and Regeneration's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. 

Speed of publication

Inflammation and Regeneration offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.

Flexibility

Online publication in Inflammation and Regeneration gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Inflammation and Regeneration are included in article alerts and regular email updates. Some may be highlighted on Inflammation and Regeneration’s pages and on the BMC homepage.

In addition, articles published in Inflammation and Regeneration may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Inflammation and Regeneration. A list of articles recently press-released by journals published by BMC is available here.

Copyright

As an author of an article published in Inflammation and Regeneration you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BMC license agreement).

For further information about the advantages of publishing in a journal from BMC, please click here.


The official journal of the Japanese Society of Inflammation and Regeneration.

Annual Journal Metrics

  • 2022 Citation Impact
    8.1 - 2-year Impact Factor
    8.2 - 5-year Impact Factor
    1.807 - SNIP (Source Normalized Impact per Paper)
    1.938 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    87 days submission to accept (Median)

    2023 Usage 
    514,127 downloads
    317 Altmetric mentions